Loss of mismatch repair proteins in sebaceous gland tumors

Journal of Cutaneous Pathology

Volumn 30, Issue 3, 2003, Pages 178-184

  Popnikolov, Nikolay K ^a   Gatalica, Zoran ^a   Colome Grimmer, Maria ^a   Sánchez, Ramón L ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Univ Galveston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PARAFFIN;

ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOSS; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MUIR TORRE SYNDROME; PROGNOSIS; PROTEIN DEPLETION; SEBACEOUS CARCINOMA; SEBACEOUS GLAND ADENOMA; SEBACEOUS GLAND DISEASE; SEBACEOUS GLAND HYPERPLASIA; SEBACEOUS GLAND TUMOR; SEBACEOUS NEVUS; TISSUE SECTION;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CARRIER PROTEINS; CHILD; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; SEBACEOUS GLAND NEOPLASMS;

EID: 0037357957     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2003.00010.x     Document Type: Article

References (31)

1. Muir EG, Yates-Bell AJ, Barlow KA. Multiple primary carcinomata of the colon, duodenum, and larynx associated with keratoakantomata of the face. Br J Surg 1967; 54: 191.
2. Torre D. Multiple sebaceous tumors. Arch Dermatol 1968; 98: 549.
3. Cohen PR, Kohn SR, Kurzrock R. Associations of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med 1991; 90: 606.
4. Schwarts RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 1995; 33: 90.
5. Lynch HT, Lynch PM, Pestel J, Fusaro RM. The cancer family syndrome: rare cutaneous phenotypic linkage to Torre's syndrome. Arch Int Med 1981; 141: 607.
6. Lynch HT, Fusaro RM, Roberts L, Voorhees GJ, Lynch JF. Muir-Torre syndrome in several members of a family with a variant of cancer family syndrome. Br J Dermatol 1985; 113: 295.
7. Hall NR, Murday VA, Chapman P et al. Genetic linkage in Muir-Torre syndrome to the same chromosomal region as cancer family syndrome. Eur J Cancer 1994; 30A: 180.
8. Honchel R, Halling KC, Schaid DJ, Pittelkow M, Thibodeau SN. Microsatellite instability in Muir-Torre syndrome. Cancer Res 1994; 54: 1159.
9. Peris K, Onorati MT, Keller G et al. Widespread microsatellite instability in sebaceous tumors of patients with the Muir-Torre syndrome. Br J Dermatol 1997; 173: 356.
10. Kruse R, Ruten A, Lamberti C et al. Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet 1998; 63: 63.
11. Rutten A, Burgdorf W, Hugel H et al. Cystic sebaceous tumors as marker lesions for the Muir-Torre syndrome. A histopathologic and molecular genetic study. Am J Dermatopathol 1999; 21: 405.
12. Ueda M, Wang Y, Sugimura H et al. A case of multiple sebaceous epithelioma: analysis of microsatellite instability. J Dermatol 1999; 26: 178.
13. Entius MM, Keller JJ, Drillenburg P et al. Microsatellite instability and expression of hNLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Clin Cancer Res 2000; 6: 1784.
14. Southey MC, Young M-A, Whitty J et al. Molecular pathologic analysis enhances the diagnosis and management of Muir-Torre syndrome and gives insight into its underlying molecular pathogenesis. Am J Surg Pathol 2001; 25: 936.
15. Mathiak M, Rutten A, Mangold E et al. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations. Am J Surg Pathol 2002; 26: 338.
16. Leach FS, Polyak K, Burrell M et al. Expression of human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res 1996; 56: 235.
17. Marcus V, Madlensky L, Gryfe R et al. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 1999; 23: 1248.
18. de Leeuw WJ, Dierssen J, Vasen HF et al. Prediction of mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumors from HNPCC-patients. J Pathol 2000; 192: 328.
19. Berends MJW, Hollema H, Wu Y et al. MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer. Int J Cancer 2001; 92: 398.
20. Harwood CA, Swale VJ, Bataille VA et al. An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients. J Invest Dermatol 2001; 116: 246.
21. Kane MF, Loda M, Gaida GM et al. Methylation of the hMLH1 promoter correlates with lack of the expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997; 57: 808.
22. Herman JG, Uma A, Polyak K et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998; 95: 6870.
23. Cunningham JM, Christensen ER, Tester DJ et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 1998; 58: 3455.
24. Veigl ML, Kasturi L, Olechnowicz J et al. Biallelic inactivation of hMLH1 by epigenetic silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci USA 1998; 95: 8689.
25. Esteller M, Catasus L, Matias-Guiu X et al. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am J Pathol 1999; 155: 1767.
26. Salvesen HB, MacDonald N, Ryan A et al. Methylation of hMLH1 in a population-based series of endometrial carcinomas. Clin Cancer Res 2000; 6: 3607.
27. Pedroni M, Sala E, Scarselli A et al. Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis. Cancer Res 2001; 61: 896.
28. Augenlicht LH, Richards C, Corner G, Pertlow TP. Evidence for genomic instability in human colonic aberrant crypt foci. Oncogene 1996; 12: 1767.
29. Heinen CD, Shivapurkar N, Tang Z, Groden J, Alabaster O. Microsatellite instability in aberrant crypt foci from human colons. Cancer Res 1996; 56: 5339.
30. Kagawa Y, Yoshida K, Hirai T et al. Microsatellite instability in squamous cell carcinomas and dysplasias of the esophagus. Anticancer Res 2000; 20: 213.
31. Lambert HM, Sipperley JO, Shore JW et al. Linear nevus sebaceus syndrome. Ophthalmology 1987; 94: 278.